MRNA Return on Equity (ROE) Analysis
Updated 6h ago·SEC filings & market data
Key Takeaway
Return on equity (ROE) measures how much profit a company generates from shareholders' money, and a -39.0% value means MRNA is currently losing money on its equity base.
Sector Performance
5th percentileMRNA
-39.0%
Sector Median
13.3%
Sector Avg
16.9%
Prior Period
-36.6%(Jul 2026)
Deep Analysis
Return on equity (ROE) measures how much profit a company generates from shareholders' money, and a -39.0% value means MRNA is currently losing money on its equity base.
That sits far below the sector median of 13.6%, placing the stock at the 4th percentile among sector peers. The year-over-year change is not available, but the quarter-over-quarter change is -6.6%, with ROE moving from -36.6% to -39.0% in the latest period. A deeply negative ROE that is also declining points to persistent shareholder value destruction and a higher risk of continued losses. This metric contradicts any optimistic outlook and directly supports the overall CAUTIOUS verdict.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about MRNA?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are MRNA's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: LOW (-67.1%), MAR (-69.0%), BMBL (-76.9%), WBA (-82.7%), NIO (-84.0%).
Learn More About Return on Equity (ROE)
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master MRNA's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full MRNA research report →MRNA
-39.0%
Sector Median
13.3%
Sector Avg
16.9%
How MRNA's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.